Apolo biotech

Apolo Biotech is an Argentina-based agricultural biotechnology company founded in 2022 that specializes in developing non-GMO, RNA-based solutions for sustainable crop protection and production. The company utilizes proprietary technology to design and stabilize exogenous RNA molecules, which are applied to crops to modulate gene expression in plants and pathogens without altering the plant's DNA. This approach mimics a vaccine-like effect, activating the natural defense systems of crops against fungi, viruses, and insects, while providing a stable, room-temperature application that eliminates the need for specialized storage or equipment. By offering a versatile, environmentally friendly alternative to traditional synthetic pesticides, the technology seeks to enhance agricultural yields while reducing the health risks associated with chemical agrochemicals. The platform leverages bioinformatics, artificial intelligence, and synthetic biology to address global agricultural challenges.

The company's solutions are particularly significant for modern agriculture as they provide a path toward reducing chemical dependency and improving sustainability in food production. Apolo Biotech operates primarily on a B2B model, targeting international markets with a focus on sustainable agricultural development and climate-resilient farming. The company has gained traction through participation in global accelerator programs, recognition from organizations like CONICET, and collaboration with industry partners to integrate RNA technology into existing agricultural practices. By focusing on crop-specific defense mechanisms, the company aims to protect environmental health and human consumers, positioning its technology as a pioneering tool in the AgTech, BioTech, and GreenTech sectors.